These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice. Notarangelo FM; Beggiato S; Schwarcz R Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro. Zakrocka I; Turski WA; Kocki T Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316 [TBL] [Abstract][Full Text] [Related]
4. Cerebrolysin lowers kynurenic acid formation--an in vitro study. Baran H; Kepplinger B Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081 [TBL] [Abstract][Full Text] [Related]
5. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Baran H; Cairns N; Lubec B; Lubec G Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415 [TBL] [Abstract][Full Text] [Related]
6. Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations. Herédi J; Cseh EK; Berkó AM; Veres G; Zádori D; Toldi J; Kis Z; Vécsei L; Ono E; Gellért L Brain Res Bull; 2019 Mar; 146():185-191. PubMed ID: 30639278 [TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration. Rejdak R; Junemann A; Grieb P; Thaler S; Schuettauf F; Chorągiewicz T; Zarnowski T; Turski WA; Zrenner E Pharmacol Rep; 2011; 63(6):1324-34. PubMed ID: 22358081 [TBL] [Abstract][Full Text] [Related]
8. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia. Kronsteiner C; Baran H; Kepplinger B Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169 [TBL] [Abstract][Full Text] [Related]
9. Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Yu P; Di Prospero NA; Sapko MT; Cai T; Chen A; Melendez-Ferro M; Du F; Whetsell WO; Guidetti P; Schwarcz R; Tagle DA Mol Cell Biol; 2004 Aug; 24(16):6919-30. PubMed ID: 15282294 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain. Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications. Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA Neurotox Res; 2017 Nov; 32(4):639-648. PubMed ID: 28733707 [TBL] [Abstract][Full Text] [Related]
12. Kynurenic acid metabolism in the brain of HIV-1 infected patients. Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102 [TBL] [Abstract][Full Text] [Related]
13. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380 [TBL] [Abstract][Full Text] [Related]
14. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain. Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133 [TBL] [Abstract][Full Text] [Related]
15. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121 [TBL] [Abstract][Full Text] [Related]
16. Kynurenine metabolism in Alzheimer's disease. Baran H; Jellinger K; Deecke L J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937 [TBL] [Abstract][Full Text] [Related]
17. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid. Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891 [TBL] [Abstract][Full Text] [Related]
18. Kynurenic acid and kynurenine aminotransferase in heart. Baran H; Amann G; Lubec B; Lubec G Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543 [TBL] [Abstract][Full Text] [Related]
19. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro. Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA Neurotox Res; 2019 Jan; 35(1):244-254. PubMed ID: 30178287 [TBL] [Abstract][Full Text] [Related]
20. The influence of cyclooxygenase inhibitors on kynurenic acid production in rat kidney: a novel path for kidney protection? Zakrocka I; Załuska W Pharmacol Rep; 2023 Apr; 75(2):376-385. PubMed ID: 36788192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]